Volume 34, 11 April 2003 04/2003
 
  SPOT ON
 

PSA-Screening for Prostate Cancer?

 
  QUESTIONABLE THERAPY
 

Corticosteroid and Long-Acting Beta Antagonist as Fixed Combination for COPD

 
  NEW ON THE MARKET
 

Vardenafil (LEVITRA): Phosphodiesterase Inhibitor No. 3

 
  REVIEW
 

Treatment of Atopic Dermatitis (I)

 
  a-t-READERS’ QUESTIONS AND COMMENTS

Does Acarbose (GLUCOBAY) Prevent Myocardial Infarction?
Dipyrone (e.g. NOVALGIN): Warnings Still Valid?

 
  IN BRIEF
 

Prevention of Cardiovascular Events by Atorvastatin (SORTIS)
Imatinib (GLIVEC) for Newly Diagnosed Chronic Myeloid Leukemia
TRIZIVIR Arm of Clinical Study Stopped
Antimycotic Fluconazole More Cheaply Available
Botulinum Toxin (BOTOX) Against Wrinkles?
Erratum

 
  CURRENT ADR NETWORK REPORT
 

Burning Tongue Sensation due to REMERON Orally Disintegrating Tablets

 
  SIDE EFFECTS
 

Optic Neuropathy With Infliximab (REMICADE)
Bufexamac (e.g. PARFENAC): Rapid Sensitization

 
© arznei-telegramm 04/2003